Senti Biosciences is trading 6.29% up now at $0.40, with the move appearing aligned with broader risk-on sentiment after cooler-than-expected July PPI and slightly higher jobless claims.
- No new company-specific announcement was identified for August 13, 2026.
- The data supported expectations for steady Federal Reserve policy, while the Nasdaq gained 0.54% at the open.
- Recent strategic-transaction news and the August 18 shareholder meeting remain relevant background but do not directly explain the move.